A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06173596
- Locations
- 🇬🇧
Research Site, Ruddington, United Kingdom
A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants
- First Posted Date
- 2023-12-07
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06160414
- Locations
- 🇬🇧
Research Site, Ruddington, United Kingdom
Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT05428696
- Locations
- 🇬🇧
Clinical Trial Site, Belfast, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath